Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Black Diamond Therapeutics Inc chart...

About the Company

black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. the company was formerly known as aset therapeutics, inc. and changed its name to black diamond therapeutics, inc. in january 2018. black diamond therapeutics, inc. was founded in 2014 and is headquartered in cambridge, massachusetts.

Exchange

NASDAQ

Website

blackdiamondtherapeutics.com

$M

Total Revenue

80

Employees

$247M

Market Capitalization

-2.32

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BDTX News

Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and I-MAB (IMAB)

22h ago, source: Business Insider

Black Diamond Therapeutics (BDTX) In a report released today ... focusing on stocks such as DBV Technologies SA – American, Amylyx Pharmaceuticals Inc, and Deciphera Pharmaceuticals. I-MAB has an ...

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

6d ago, source:

Dosed first patient in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCClinical data on track for Q3 2024 in Phase 2 ...

Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...

4d ago, source:

Upcoming Milestones: Anticipated data releases for GBM results in Q2 2024 and initial results for BDTX-4933 in Q4 2024.

Black Diamond: Q4 Earnings Snapshot

6d ago, source:

CAMBRIDGE, Mass. — CAMBRIDGE, Mass. — Black Diamond Therapeutics, Inc. (BDTX) on Tuesday reported a loss of $19.4 million in its fourth quarter. On a per-share basis, the Cambridge, ...

Black Diamond Therapeutic: Q4 Earnings Insights

6d ago, source:

Black Diamond Therapeutic BDTX -1.50% + Free Alerts reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:00 AM.

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

13d ago, source:

Abstract accepted for oral presentation on the evolving EGFR mutational landscape in NSCLC and MasterKey profile of BDTX-1535 addressing a broad spectrum of mutationsCAMBRIDGE, Mass., March 05, 2024 ...

Black Diamond High named model continuation school

on MSN ago, source:

Pittsburg’s Black Diamond High School this week was named a 2024 California Model Continuation High School, marking the third ...

Black Diamond Appoints Creative Director for the Brand

6d ago, source: sgbonline

Black Diamond Equipment appointed Kasey Jarvis as the brand’s creative director.

Aprea Therapeutics, Inc.

1y ago, source: CNN

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer ...

Two charged with second-degree murder in connection to killing of 18-year-old man on Lakeside Avenue

13d ago, source: WRIC on MSN

Two suspects have been charged with second-degree murder in connection to the shooting death of a man that occurred in ...

Cheese recall due to listeria outbreak impacts Sargento

11d ago, source: Yahoo Finance

"This news stemmed from California-based Rizo-Lopez Foods Inc.'s recall last month of its Cotija cheese due to a related ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...